Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company develops novel T cell vaccines using patented adjuvants to enhance T cell immunity against cancer. This approach enables more effective immunotherapy options for patients facing various types of cancer.